Ventas, Inc. $VTR Shares Sold by Vestcor Inc

Vestcor Inc decreased its stake in Ventas, Inc. (NYSE:VTR) by 35.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 79,030 shares of the real estate investment trust’s stock after selling 43,780 shares during the period. Vestcor Inc’s holdings in Ventas were worth $6,115,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. GoalVest Advisory LLC acquired a new position in shares of Ventas in the 4th quarter valued at $26,000. Wiser Advisor Group LLC acquired a new position in shares of Ventas in the 3rd quarter valued at $27,000. Elyxium Wealth LLC acquired a new position in shares of Ventas in the 4th quarter valued at $33,000. True Wealth Design LLC boosted its holdings in shares of Ventas by 32.0% in the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after buying an additional 138 shares in the last quarter. Finally, AlphaQuest LLC boosted its holdings in shares of Ventas by 1,848.5% in the 3rd quarter. AlphaQuest LLC now owns 643 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 610 shares in the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Stock Up 3.8%

Shares of NYSE:VTR opened at $82.13 on Friday. The company has a market cap of $39.93 billion, a price-to-earnings ratio of 149.33, a PEG ratio of 1.81 and a beta of 0.71. The firm’s 50-day simple moving average is $85.05 and its 200-day simple moving average is $82.36. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a fifty-two week low of $61.76 and a fifty-two week high of $91.06.

Ventas (NYSE:VTR) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm’s revenue was up 22.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities research analysts predict that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. Ventas’s payout ratio is presently 378.18%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Morgan Stanley set a $90.00 target price on shares of Ventas in a report on Friday, February 13th. Argus set a $88.00 target price on shares of Ventas in a report on Tuesday, February 10th. The Goldman Sachs Group restated a “buy” rating and issued a $110.00 target price on shares of Ventas in a report on Tuesday, May 19th. UBS Group upped their target price on shares of Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a report on Monday, May 4th. Finally, Evercore restated an “outperform” rating and issued a $95.00 target price on shares of Ventas in a report on Wednesday, April 29th. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $95.19.

Insider Activity

In related news, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The stock was acquired at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This represents a 3.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by insiders.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.